Claritev Corporation (CTEV) vs SOPHiA GENETICS SA (SOPH)
- Claritev Corporation CTEV 22.88 +13.16%
- SOPHiA GENETICS SA SOPH 7.09 +7.10%
Claritev Corporation and SOPHiA GENETICS SA are both Health Information Services companies. SOPHiA GENETICS SA is the larger, with a market value of $563.6M against $342.7M — 1.6× the size. SOPHiA GENETICS SA grew revenue faster over the last twelve months: 24.1% against 6.32%. Claritev Corporation has the higher net margin (−28.5% vs −89.2%) and the higher return on invested capital (0.47% vs −200.9%). Across the 17 metrics below, Claritev Corporation leads on 12 and SOPHiA GENETICS SA on 5.
Valuation
Profitability
| Metric | CTEV | SOPH | Health Information Services median |
|---|---|---|---|
| Gross margin | 72.97% | 66.43% | 59.61% |
| Operating margin | 3.27% | (80.99%) | (10.54%) |
| Net margin | (28.46%) | (89.18%) | (16.14%) |
| Free cash flow margin | (1.80%) | (45.64%) | 0.00% |
| Return on equity | 172.76% | (125.67%) | (3.15%) |
| Return on assets | (5.76%) | (46.60%) | (5.62%) |
| Return on invested capital | 0.47% | (200.89%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack